glutathione fda highlights concerns with using dietary ingredient to compound sterile injectables list of fda approved glutathione

FDA Safety Concerns The FDAs current compounding information states that BPC-157 may present immunogenicity risks for certain routes and raises challenges involving peptide impurities and active-ingredient characterisation

your liver, kidneys, gut, lungs, lymphatic system, and skin work every day to process and remove waste products

doi: 10.1111/ijcp.12771

I think that it should be done, honestly, because it's a low hanging fruit

Considering these studies utilised the same dose and timing of ingestion as other studies demonstrating ergogenic effects in resistance exercise performance, the use of CM seems ineffective at improving cycling performance in trained individuals